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ABSTRACT
In this review, we highlight the variations of gut resistome studies, which may preclude compar-
isons and translational interpretations. Of 22 included studies, a range of 12 to 2000 antibiotic
resistance (AR) genes were profiled. Overall, studies defined a healthy gut resistome as subjects
who had not taken antibiotics in the last three to 12 months prior to sampling. In studies with de
novo assembly, AR genes were identified based on variable nucleotide or amino acid sequence
similarities. Different marker genes were used for defining resistance to a given antibiotic class.
Validation of phenotypic resistance in the laboratory is frequently lacking. Cryptic resistance,
collateral sensitivity and the interaction with repressors or promotors were not investigated.
International consensus is needed for selecting marker genes to define resistance to a given
antibiotic class in addition to uniformity in phenotypic validation and bioinformatics pipelines.
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Introduction
Antibiotic resistance is a global public health con-
cern and thus recognition of its reservoirs could
facilitate the control of its dissemination.
Traditionally, studies of antimicrobial resistance
(AR) genes in bacteria started from massive screen-
ing of antibiotic resistance phenotypes using macro-
or micro-broth dilution methods.1–3 For bacterial
isolates displaying resistance phenotypes, total geno-
mic DNA is extracted and probed for candidate AR
genes using polymerase chain reaction (PCR)-based
method or comparative whole-genome sequencing
with reference to sensitive type strains.2 If
a candidate resistance gene could not be identified,
genomic DNA is cloned into expression vectors and
then transformed into a heterologous sensitive bac-
terial host for molecular and phenotypic
characterization.3 In addition to being time-
consuming, this technique is limited to bacteria
that can be cultivated.
In recent years, the advent of affordable high-
throughput sequencing and analysis applied to
online antibiotic resistance gene databases enables
the avoidance of bacterial culture, facilitating mas-
sive resistome-wide studies of potential reservoirs
of antibiotic resistance genes.4–8 The ubiquity of
resistance genes was exemplified by their unanti-
cipated isolation from various environmental habi-
tats waste water treatment plant and soil to food
production chain and wild animals.9–11
The term resistome is defined as the complete
collective assemblage of antibiotic, antiseptic and
heavy metal resistance genes in a microbial
ecosystem.12 Studies have applied this definition
variably with considerable heterogeneity in can-
didate genes, methodology and bioinformatics
pipelines, precluding direct comparison across
studies.5–7,13,14 Several reports employed high-
throughput microfluidic PCR or customized
microarrays by designing probes with reference
to existing AR gene databases and targeted
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a selection of resistance genes,15–17 with the
resulting number of AR genes varying from
less than 507,14,18 to thousands.15,19 Across stu-
dies, disparate genes were selected to represent
resistance to a given antibiotic class.7,14,16,20
Another issue is in comparing gene and/or pro-
tein sequence similarities and defining functional
conservation. In sequence-based meta-genomic
studies, de novo assembled contigs were com-
pared to the existing AR gene databases. Where
the assembled contigs displayed sequence simi-
larity beyond a defined threshold, phenotypic
resistance was assumed. The degree of similarity
was arbitrary, ranging from 80% of amino acid
sequence identity6 to 95% nucleotide sequence
identity.21,22 The function of the detected resis-
tance genes was only occasionally validated by
expressing in competent bacterial hosts.8,19,20,23
It is well-established that a single amino acid
substitution could sufficiently change the sus-
ceptibility level of a strain by altering the bind-
ing affinity of the drug target site to
a corresponding antibiotic.24 In cases where up
to 20% difference in the amino acid sequence
was observed, the resistance phenotype of the
bacterial strains concerned would therefore be
questionable. In sequence-based meta-genomic
studies, the genetic context of the resistant
genes, or the flanking regions containing promo-
ter- and repressor-sequences that define the bac-
terial host origin, was not consistently reported.
This should provide important information on
possible bacterial hosts, gene expression, and
horizontal transferability. The possible bacterial
hosts for a given set of antibiotic resistance
genes were occasionally predicted using network
analysis lacking downstream resistance pheno-
type validation.25
We reviewed the literature of the human gut
resistome determined in healthy populations
from various geographical locations. We high-
light the characteristics of these studies; the
methodologies used in their analyses, and the
range of the magnitude of the resistome. We
also identify variables that require careful defini-
tion and the adoption of a consensus to enable
comparisons to be made across studies.
Methods
Bibliographic search and study selection
Search strategy was developed using the
MEDLINE Ovid platform (Table S1), which was
then translated for use in electronic databases
EMBASE, MEDLINE (PUBMED), Web of
Science, and Scopus. Briefly, relevant articles
were identified using Medical Subject Heading
(MeSH) or Title/Abstract keywords from incep-
tion to May 2019. All citations were imported
into Endnote X8 software by which duplicates
were removed. Two researchers (JH and NB) per-
formed article screening and data verification,
respectively, according to predefined inclusion
and exclusion criteria. Disagreement on study
selection was resolved through discussion. This
study was reported according to the Preferred
Reporting Items for Systematic Reviews and Meta-
analysis (PRISMA) statement.26
Inclusion and exclusion criteria
All primary studies with human fecal specimens
collected from healthy population or secondary
analyses of its kind were included. Studies on
population with high risk for carrying antibiotic
resistance genes, such as the critically ill, were
excluded. Conference abstracts, editorials, sys-
tematic reviews, and meta-analyses were excluded.
Other exclusion criteria were set in terms of study
population, publication type, and study type. The
pre-defined inclusion and exclusion criteria are
summarized in Table S2.
Data extraction and quality assessment
Full text of the eligible studies were reviewed and
the following data extracted: First author, year of
publication, study design, number of fecal speci-
mens, specific antibiotic resistance genes, labora-
tory methods, and bioinformatic pipelines.
Whenever appropriate, the corresponding authors
would be contacted by e-mail for clarification. The
quality of the included studies was rated by sub-
items of Newcastle–Ottawa scale for non-
randomized observational studies, a tool with
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established content validity and inter-rater
reliability.27 The representativeness of the study
cohort and the ascertainment of antibiotic expo-
sure were determined. Two independent reviewers
(JH and NB) rated the studies according to the
scale. To ensure reliability of the review process,
10% of the articles in the final data set were
reviewed by another reviewer (MI). Any discre-
pancies were resolved by discussion.
Effect sizes and publication bias
Despite multiple reports of the prevalence of anti-
biotic resistance genes on the same population were
identified, the small sample size and inconsistent use
of reference genes precluded such an effect size from
pooling. In terms of publication bias, a traditional
funnel plot using logarithm of effect size against
standard error does not apply to proportion data
sets due to its inherent nature of asymmetry for
extreme proportions. Neither classic fail-safe N nor
Orwin’s fail-safe N would be applicable for preva-
lence data because statistical significance or trivial
levels do not exist for proportion estimates.
Results and discussion
Study selection, countries of origin, cohort
representativeness, and exposure ascertainment
The initial search returned 107 articles. After
screening titles and abstracts, 86 full-texts were
reviewed. Nineteen of these met the inclusion cri-
teria but were not exempted from the exclusion
criteria. Three additional studies were identified by
manually checking reference lists of these 19
studies (Figure 1). Of the 22 studies included in
this review (Table S3), 15 were primary studies
involving subject recruitment and specimen
collection.4,6,7,14–20,22,23,28–30 These covered popu-
lations originated from 18 countries, namely
Afghanistan, Canada, China, Denmark, Eritrea,
Finland, France, Germany, Iraq, Italy, Norway,
Peru, Spain, Syria, Tanzania, The Netherlands,
United Kingdom, and the United States. No stu-
dies were conducted in 90% of the countries as
defined by the United Nations which included
more than 193 countries. The remaining seven
studies were re-analysis of publicly available
datasets.5,8,13,21,25,31,32 With reference to the num-
ber of population by countries reported by the
United Nations,33 the number of recruited subjects
ranged from 0.72 in China to 765 in the
Netherlands per 10 million population (median =
19.07, interquartile range 4.56–37.10) (Figure 2).
Except for a Dutch study for which a general
population-based cohort involving 1,135 indivi-
duals derived from 167,000 subjects across three
provinces,18 the remaining studies were either
based on convenient samples or did not describe
how the cohorts were derived. Antibiotic intake is
one of the key factors that may alter the collection
of antibiotic resistance genes or resistome.16 In this
connection, ascertainment of antibiotic exposure
prior to fecal specimen collection is important.
Nonetheless, the period free from antibiotic expo-
sure ranged from 3 months,3 6 months,16,22 to 12
months.29,30 Notably, the remaining primary stu-
dies did not describe antibiotic exposure in their
population. However, they did not report higher
number of resistant genes. The details of the
included studies are presented in Table 1.
Figure 1. Study selection.
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Ambiguous definition of a healthy human gut
resistome
Human gut resistomes are by large defined as the
collection of antibiotic resistance genes present in
the gut microbiota.14–19 This collection varied
from 10 AR genes encoding resistance to five
drug classes (β-lactams, tetracyclines, macrolides,
aminoglycosides, and quinolones)14 to more than
2,900 AR genes classified into 369 gene types.15
These 369 AR gene types could be broadly classi-
fied into resistance to six drug classes including β-
lactams and tetracyclines.15 The number of AR
genes surveyed for a given antibiotic class also
varied considerably. For instance, more than 30
tetracycline resistance genes were tested in one
study15 but only tetM and tetQ were investigated
in another.14 Nonetheless, they both reported the
detection rate of tetracycline resistance in the gut
resistome, which was initially limited by the num-
ber of genes surveyed. Interestingly, the highly
prevalent tetW gene in healthy subjects16 was not
investigated in another study targeting healthy
people after international travel.14 While the inter-
action between AR genes per se and their repres-
sors or promoters is well documented, the
inclusion of transposons, integrons, and AR gene-
associated gene regulators has been variably
reported. Several studies did not detect AR gene-
associated genetic elements.14,16,20 No study has
considered collateral sensitivity and silent AR
genes in the healthy gut resistome. In metage-
nomic studies where de novo assembly was used
to detect novel AR determinants, the identity ran-
ged from less than 60% amino acid sequence
identity19 to more than 99% nucleotide sequence
similarity to define recently horizontal transferred
elements.21 A stringent threshold could potentially
reduce the number of AR genes identified, and
vice versa. Collectively, the difference of the num-
ber of AR genes, choice of marker AR gene to
represent a functional antibiotic class and the
degree of sequence identity to define a putative
determinant hinder comparison across studies.
Epidemiological factors shaping the healthy gut
resistome
At an individual level, the gut resistome landscape is
largely shaped by age,15 sex,18 co-morbidities,16 gut
microbiota composition,25 living conditions such as
household environment,19 and daily life exposure.6
For instance, the Hadza hunter-gatherer had a gut
resistome profile similar to that in soil.6 While anti-
biotic exposure was anticipated to alter the human gut
resistome in people with existing co-morbidities,16 the
gut resistome appears to be highly resilient in healthy
subjects following short-term experimental exposure
to antibiotics.17,22 At the population-wide level,
a single ecological study suggested that the gut resis-
totype was associated with the country-level con-
sumption of antibiotics.28 In the 21st century, the
mobility of humans across countries also accounts
for the variation of gut resistome. Despite an initially
low prevalence of blaCTX-M (9%) and qnrB (6.6%)
Figure 2. Geographical distribution of studies included in this review. The color intensity indicates the number of participants
sampled per 10 million population by countries according to data in the World Data Bank, the United Nations.
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before departure from the Netherlands, a country
with low prevalence of antibiotic resistance, as many
as 33.6% and 36.9% of the Dutch travelers acquired
blaCTX-M and qnrB genes, respectively, following tra-
vel to Southeast Asian and the Indian subcontinents.14
Cross-country migrations of refugees and asylum see-
kers also potentially altered the gut resistome amongst
the local population due to higher prevalence of resis-
tance genes in such developing countries as
Afghanistan, Iraq, and Syria.7 A recent study in the
UK has shown that the two major risk factors for
carriage of CTX-M in the healthy community are
travel to an area of high occurrence and birth-origin
in such countries which is associated with frequent
travel to those areas of the world.34,35
Contemporary approaches to investigate human
intestinal resistome
Essentially, three approaches of studying the gut resis-
tome have been identified. Classically (and histori-
cally), a selected pool of AR genes was detected by
either PCR or customized microarrays.7,14–17s
Different marker AR genes were chosen to represent
resistance phenotype to a given antibiotic class.14–17
These methods were also limited to the small number
of AR genes possibly be detected, reducing the repre-
sentativeness of the AR gene repertoire. The second
approach employed total bulk DNA directly isolated
from samples, for which only known AR or related
genes with similar sequence identity were detected. In
thismethod,DNAwas extracted from fecal specimens
and sequenced with a depth of 1.2Gb to 12.6Gb per
sample.4,19 Contigs were then assembled based on
user-defined settings, the sequence of which was com-
pared against existing antibiotic resistance gene data-
bases such as Comprehensive Antibiotic Resistance
Database (CARD).,18,19,22,24 Lahey beta-lactamase
database,19 Antibiotic Resistance Gene-ANNOTation
(ARG-ANNOT),13 Antibiotic Resistance Database
(ARDB),13,25,28 and Resfinder.21 A combination of
these databases could also be included in a study to
increase the detection rate of AR genes.13,19,30 Based
on local AR gene distribution, additional augmenta-
tion could also be possible.28 The third approach
entails direct fragmentation of DNA extracted from
fecal samples and cloned into heterologous hosts such
as E. coli using shuttle vectors including plasmids,19
fosmids8 or bacterial artificial chromosomes,T
ab
le
1.
(C
on
tin
ue
d)
.
Re
f.
Co
un
tr
y(
ie
s)
Sa
m
pl
e
si
ze
M
et
ho
d(
s)
AR
G
(N
)a
Pi
pe
lin
e(
s)
Re
fe
re
nc
e
D
at
ab
as
e(
s)
Ke
y
fin
di
ng
s
Li
m
ita
tio
ns
28
D
en
m
ar
k,
Sp
ai
n,
U
SA
25
2
Se
qM
et
a
3,
49
6
M
O
CA
T
AR
D
B
Th
e
m
os
t
pr
ev
al
en
t
hu
m
an
gu
t
AR
G
s
w
er
e
th
os
e
th
at
en
co
de
d
re
si
st
an
ce
to
an
tib
io
tic
s
us
ed
in
an
im
al
s
in
a
co
un
tr
y-
sp
ec
ifi
c
m
an
ne
r.
O
nl
y
th
re
e
de
ve
lo
pe
d
co
un
tr
ie
s
w
er
e
in
vo
lv
ed
.
29
U
SA
2
Fu
nM
et
a
N
A
N
A
N
CB
I
H
al
f
of
th
e
re
si
st
an
ce
ge
ne
s
re
co
ve
re
d
fr
om
ae
ro
bi
c
gu
t
is
ol
at
es
w
er
e
id
en
tic
al
to
th
at
in
pa
th
og
en
s.
Th
e
m
aj
or
ity
of
gu
t
co
m
m
en
sa
ls
w
as
an
ae
ro
bi
c.
30
G
er
m
an
y
2
Se
qM
et
a
N
A
D
IA
M
O
N
D
CA
RD
Th
e
gu
t
re
si
st
om
e
in
tw
o
pe
rs
on
s
ch
an
ge
d
di
ffe
re
nt
ly
in
re
sp
on
se
to
ci
pr
of
lo
xa
ci
n
tr
ea
tm
en
t.
G
iv
en
se
qu
en
ce
re
ad
s
di
d
no
t
sp
an
th
e
w
ho
le
AR
G
le
ng
th
,i
ts
fr
eq
ue
nc
y
co
ul
d
no
t
be
id
en
tif
ie
d.
31
U
SA
29
Se
qM
et
a
21
Pr
od
ig
al
,
BL
AS
TP
D
ee
pA
RG
Si
xt
y
fo
ur
AR
G
s
w
er
e
sh
ar
ed
am
on
gs
tt
he
gu
tr
es
is
to
m
es
fr
om
ch
ic
ke
ns
,p
ig
s
an
d
hu
m
an
s.
Th
e
ge
ne
tic
co
nt
ex
ts
of
th
e
AR
G
s
w
er
e
un
cl
ea
r.
32
M
al
aw
i,
U
SA
,
Ve
ne
zu
el
a
11
0
Se
qM
et
a
70
BL
AS
T+
AR
D
B,
Re
sF
am
s
An
tib
io
tic
re
si
st
an
ce
an
d
vi
ru
le
nc
e
ge
ne
s
ar
e
co
rr
el
at
ed
an
d
m
ay
be
co
-s
el
ec
te
d.
Re
su
lts
w
er
e
ba
se
d
on
se
qu
en
ce
an
al
ys
is
w
ith
ou
t
do
w
ns
tr
ea
m
la
bo
ra
to
ry
va
lid
at
io
n.
a N
um
be
r
of
an
tib
io
tic
re
si
st
an
ce
ge
ne
s
(A
RG
)
su
rv
ey
ed
or
an
no
ta
te
d;
Fu
nM
et
a,
fu
nc
tio
na
l
m
et
ag
en
om
ic
s;
M
ar
ily
n,
M
ar
ily
n
Ro
be
rt
’s
w
eb
si
te
fo
r
m
ac
ro
lid
es
an
d
te
tr
ac
yc
lin
e
re
si
st
an
ce
ge
ne
s;
M
ER
G
EM
,
M
ob
ile
El
em
en
ts
an
d
Re
si
st
an
ce
G
en
es
En
ha
nc
ed
fo
rM
et
ag
en
om
ic
s;
M
f-
PC
R,
m
ic
ro
flu
id
ic
PC
R;
PA
TR
IC
,P
at
ho
sy
st
em
s
Re
so
ur
ce
In
te
gr
at
io
n
Ce
nt
er
;R
ef
,r
ef
er
en
ce
;S
eq
M
et
a,
se
qu
en
ce
-b
as
ed
m
et
ag
en
om
ic
s;
SO
AP
,s
ho
rt
ol
ig
on
uc
le
ot
id
e
an
al
ys
is
pa
ck
ag
e.
6 J. HO ET AL.
depending on the insert size.20,23 This method has the
advantage of identifying novel AR genes and confirm-
ing the role of the AR genes albeit its expression may
differ in the heterologous host. Collectively, targeted
AR gene detection will be inexpensive, allowing sur-
veys be conducted in resource-limited settings such as
low- and middle-income countries. In places where
affordability is not a concern, an initial sequence-
based metagenomic survey can be conducted to iden-
tify putative AR genes, followed by confirming its
biological role in an expressive bacterium such as
E. coli. All in all, while metagenomic shotgun sequen-
cing can sidestep cultivability of gut commensals in
which anaerobic bacteria predominate, its small size of
contig assembly renders the characterization of anti-
biotic-resistant gene harboring transposons or other
mobile elements difficult.21 This can be overcome by
constructing and screening of fosmid libraries using
longer DNA fragments isolated from pulsed-field gel
electrophoresis assuming that the gene encodes the
same phenotype in both the heterologous host and the
native bacterium.8 The bioinformatic pipelines and
reference databases for gut resistomes are summarized
in Tables 2 and 3, respectively.
Common antibiotic resistance determinants
found in healthy human gut
Of 180 fecal metagenome datasets tested, the AR
genes aadE, bacA, acrB, tetM, tetW, vanR, and
vanS were present in all people.25 The healthy
human gut is expected to carry AR genes which are
associated with intestinal anaerobic commensals
such as catA and tetW encoding chloramphenicol
and tetracycline resistances, respectively.16
Interestingly, functional metagenomic studies have
recovered clones with AR genes encoding resistance
to β-lactamases (blaTEM), macrolides (ermB, ereA),
aminoglycosides (strA, strB), trimethoprim (dfrA14)
and sulfonamides (sul2) other than bacitracin and
tetracyclines.20 To date, genes conferring resistance
to isoniazid, rifampicin, oxazolidinones have not yet
been reported in the healthy human gut
microbiome.
Quality assessment
Of 22 included studies, seven were re-analysis of
publicly available metagenomic datasets whereas
15 were primary studies of which only one was
population based.18 The remaining used either
convenient samples or less than 10 samples with
limited representation of the target population.
Only six studies reported prior exposure to anti-
biotics amongst the participants.5,16,20,22,29,30 The
scores for each study as evaluated by Newcastle–
Ottawa scale for non-randomized cohort studies
are summarized in Table S4.
Discussion
The abundance and diversity of human gut micro-
biota and its association with physiological func-
tions are well recognized. Nonetheless, their roles
as potential carriers of AR genes have received
unequal attention. With the increasing prevalence
of multiple drug-resistant bacteria worldwide, the
potential reservoir of AR genes in the gut
Table 2. Common bioinformatic pipelines for gut resistome analysis.
Pipeline Comments
Latest
Update Website Ref.
fARGene ARGs can be identified and reconstructed directly from metagenomic data,
suitable for unknown resistomes.
May 2019 https://github.com/fannyhb/
fargene
36
ResFinder Allows the identification of acquired AMRs and chromosomal mutations. Apr 2019 https://cge.cbs.dtu.dk/services/
ResFinder
37
ARG-OAP Online pipeline for fast annotation of ARGs. June 2018 http://smile.hku.hk/SARGs 38
GROOT Combination of a variation graph representation of genes with a Forest
indexing scheme.
April 2019 https://github.com/will-rowe
/groot
39
ARIBA Efficient for identifying acquired AMR genes and variants. June 2019 https://github.com/sanger-
pathogens/ariba
40
DeepARG This is a deep machine learning algorithm for ARGs. June 2017 https://bench.cs.vt.edu/deeparg 41
ShortBRED Profiling protein families of ARGs from shotgun metagenomics data. Unclear http://huttenhower.sph.garvard.
edu/shortbred
42
ARDB, Antibiotic Resistance Gene Database; CARD, The Comprehensive Antibiotic Resistance Database; MERGEM, Mobile Elements and Resistance
Genes database Enhanced for Metagenomics; RED-DB, Resistance Determinants Database; SARG, Structured Antibiotic Resistance Genes.
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microbiota and the possibility of their transfer to
human pathogens are of concern. In this article,
we systematically reviewed studies on healthy
human digestive tract resistome and highlight the
methodological heterogeneity across studies which
may potentially generate biased results.
The environmental resistome has been exten-
sively studied. It was speculated that AR genes
have been selected because of human use of anti-
biotics. Isolation of AR genes in ancient perma-
frost and in communities without anthropogenic
activity disproved this hypothesis, suggesting that
antibiotic resistance genes may pre-date the wide-
spread use of naturally occurring antibiotics.12 The
rapid emergence of resistance to sulfonamides in
the 1930s demonstrates that a non-natural chemi-
cal entity can readily select for genes encoding
enzymes with preexisting functionality in bacteria
to confer resistance to these synthetic agents. The
presence of relevant antibiotic resistance
mechanisms in organism such as Streptomyces
from which the antibiotics was isolated for clinical
use was assumed to be a part of self-protection
mechanism for survival.12 This finding led to
numerous studies on disparate microbial commu-
nities, predominantly in the soil resistome which is
reviewed elsewhere.9
Defining an antibiotic resistance gene could be
difficult, particularly in cases where sequence-
based metagenomic studies have identified a gene
with considerable similarity to a known AR gene
but without knowledge of its phenotype.31 This is
further complicated by using de novo assembly
which identifies thousands of potential AR genes
with variable degree of similarity to the existing
known AR genes.21 The number of candidate AR
genes thus identified may actually reflect the cutoff
of similarity to define an AR gene per se, without
reference to the functional significance of the dif-
ference in DNA sequence, such as that based on
Table 3. Reference databases for antibiotic resistance genes.
Database Comments
Latest
Update Information contained Website Ref.
ARDB No longer being maintained. All information
has moved to CARD.
July
2009
13,293 genes, 377 types,
257 antibiotics, 632
genomes, 933 species and
124 genera
https://ardb.cbcb.umd.
edu/
43
ARGO Data was restricted to β-lactamase, tetracycline,
and vancomycin genes.
Unclear 555 β-lactamases and 115
vancomycin resistance
genes reported before
2004.
http://www.argodb.org/ 44
ARG-ANNOT Based on a local BLAST program in Bio-Edit
software, allowing offline analysis.
Unclear 1,689 antibiotic resistance
genes
No longer available 45
CARD This is one of the most extensive AMR
sequence databases, covering intrinsic,
mutation-driven, and acquired resistance,
including mobile genetic elements.
April 2019 2570 reference sequences,
1233 SNPs, 7305 plasmids,
5524 chromosomes
https://card.mcmaster.
ca/
46
Lahey Clinic
database
This database provides comprehensive
information on β-lactamase genes.
May 2019 β-lactamase classification
and amino acid sequences
for TEM, SHV, and OXA
genes.
https://www.lahey.org/ 47
SARG The redundant sequences were removed and
query sequence detection optimized.
June 2018 9080 sequence belonged
to 189 ARGs subtypes.
http://smile.hku.hk/
SARGs
38
MERGEM This database contains resistance genes
suitable for k-mer filtering.
Unclear The website is no longer
maintained
http://www.mergem.gen
ome.ulaval.ca/
48
RED-DB Both partial and complete coding sequences
are available.
May
2019
10,742 non-redundant
genes covering ten
antibiotic classes.
http://www.fibim.unisi.
it/REDDB
-
ResFams Database of proteins encoding drug resistance,
organized by ontology.
Feb 2018 2,454 unique sequences,
presenting 54 Resfams
protein families.
http://www.dantaslab.
org/resfams
49
AMRFinder Database of AMR protein and gene
nomenclature with hidden Markov models
June 2019 4,579 AMR protein
sequences and more than
560 hidden Markov
models.
https:/www.ncbi.nlm.
nih.gov/pathogens/anti
microbial-resistance
/AMRFinder/
50
ARDB, Antibiotic Resistance Gene Database; CARD, The Comprehensive Antibiotic Resistance Database; MERGEM, Mobile Elements and Resistance
Genes database Enhanced for Metagenomics; RED-DB, Resistance Determinants Database; SARG, Structured Antibiotic Resistance Genes.
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the active sites that determine resistance. In addi-
tion, sequence-based metagenomic approach is
limited by the variability of expression of the AR
genes in heterologous hosts. Some of the AR genes
identified by sequence similarity may be silent or
nonfunctional in the native hosts.
In multiple studies, AR genes appear to be
exclusively present in gut commensals.5,16,20
Longitudinal analysis of fecal metagenomic assem-
bly from critically ill subjects surprisingly identi-
fied that all antibiotic-resistant genes including
aph(2”)-Ib and aadE-like gene were carried by
mobile genetic elements such as plasmids and
insertion sequences in anaerobic gut commensals
among Firmicutes, Bacteroidetes, and
Actinobacteria.16 The aminoglycoside resistance
genes were harbored by butyrate-producing
Clostridium cluster IV commensal which are pre-
sent in healthy humans.16 These genes encoding
clinically relevant drug resistance, if transferred to
pathogens, will pose a threat to the patients.
In recent decades, the increasing use of disin-
fectants in the food industry and clinical settings
led to research on reduced susceptibility to disin-
fectants. Surprisingly, studies on gut resistome did
not consider the presence of genes encoding
reduced susceptibility to biocides such as quatern-
ary ammonium compounds and triclosan. It has
been shown that environments with high concen-
trations of quaternary ammonium biocides select
for high carriage rates in bacteria of Class 1 inte-
grons and therefore might be expected to co-select
for AR genes.51 Numerous studies employed quan-
titative polymerase chain reaction and commer-
cially available microarray assays to study gut
resistome. These findings would therefore be lim-
ited to known resistance genes. Coupled with
functional screen of large DNA inserts in appro-
priate vectors and expression hosts, functional
metagenomics appears to be a promising robust
molecular tool to identify novel antimicrobial
resistance genes and their origins. For instance,
functional screens of specimens with known plas-
mid-borne resistance genes detected in microar-
ray-hybridization did not recover any transformed
clones with plasmid-borne resistant determinants
but instead detected a clone with resistant gene
carried in chromosome.20 This discrepancy may
indicate that the genes detected by microarray
may be silent and that both determinants may be
present in the microbial community.
The use of metagenomic shotgun sequencing
circumvents the problem of non-culturable gut
commensals.52–54 The results are often limited by
the bioinformatics pipelines and ARG database(s)
selected for analyses. Recently, the National
Center for Biotechnology Information (NCBI)
produced a high-quality, curated, AMR gene
reference database consisting of up-to-date pro-
tein and gene nomenclature. A comparison of the
susceptibilities of three common Gram-negative
foodborne pathogens against the database gave
high consistent predictions of 98.4%. This data-
base is designated as AMRFinder with more than
390,000 entries, which is one of the most compre-
hensive databases.50 However, the small size of the
contigs which are assembled renders the charac-
terization of the resistance-gene harboring trans-
posons or other mobile elements difficult.21 This
can be overcome by constructing and screening of
fosmid libraries using longer DNA fragments iso-
lated from pulsed-field gel electrophoresis assum-
ing that the gene encodes the same phenotype in
both the heterologous host and the native
bacterium.8
Strengths and limitations of this review
To our knowledge, this is the first systematic
review on studies investigating healthy human
gut resistome. Using pre-defined inclusion and
exclusion criteria, we comprehensively searched
the available databases for relevant studies. Our
review highlights the methodological heterogeneity
across studies that demands harmonization.
However, our review is limited by the small sample
size in most of the included studies and that most
of them were based on convenient samples or re-
analysis of publicly available datasets,
a shortcoming which will be addressed as newer
technologies are developed and deployed.
Conclusions
In conclusion, there are considerable methodolo-
gical heterogeneities across studies. The choice of
marker genes to represent resistance phenotype to
a given antibiotic class varied. Uniformity in
GUT MICROBES 9
phenotypic validation and bioinformatics pipelines
will need to be addressed to facilitate inter-study
comparisons.
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